Focus Partners Advisor Solutions, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1868872
SAINT LOUIS, MO
Position in TAK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$229,261
+$43,154 QoQ
Shares Held
14,302
+42.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#199
of 375 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Focus Partners Advisor Solutions, LLC holds $5,018,095 across 7 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
11,434 | $1,927,086 | |
| 2 | VTRS |
Viatris Inc
|
88,753 | $1,409,397 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,467 | $794,864 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,587 | $324,807 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
14,302 | $229,261 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
13,190 | $191,123 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
33,624 | $141,557 |
All Filings in TAK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,261 | 14,302 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $186,107 | 10,049 | Shares | Other | 2026-05-13 | |
| 2025-06-30 | $158,078 | 10,225 | Shares | Other | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||